Mild Cognitive Impairment (MCI) is a critical transitional stage between normal aging and dementia.
Early detection is crucial for timely interventions, yet the range of symptoms complicates accurate identification. As a result, patients often do not receive the necessary care and deteriorate into dementia.
There are multiple subtypes of MCI – with Vascular MCI being the most prevalent in Asia. Vascular MCI is linked to risk factors such as hypertension, diabetes and hyperlipidemia.
of patients experience decline to Dementia annually
of MCI cases in Asia are Vascular
individuals are affected by the vascular risk factors in Asia
Clinically-validated games that detect MCI in just 10 to 15 minutes.
Generated reports that guide the next steps in care.
Early detection and differentiation of sub-types enhance patients’ chance of receiving appropriate, timely interventions before it deteriorates.
Explore our upcoming product designed to elevate the clinical approach to detect and manage cognitive health
We conducted in-depth studies on Mild Cognitive Impairment and Cerebral Small Vessel Disease.
We discovered critical brain functions that displayed a significant role in the development of Vascular Mild Cognitive Impairment. ReCOGnAIze’s AI model leverages these relationships to gather data through simple games, providing results.
I have looked at the prototype and the preliminary data and it looks promising especially the potential utility in early detection of vascular MCI. The app could be explored to employ easily as a case finding tool in the community.
Clinician at a Public Hospital, Singapore
If I had a fast, easy-to-use, and validated tool for vascular MCI, initiation of early intervention will be made possible.
General Practitioner at a Private Clinic, Singapore
Due to delayed diagnosis and consultation, patients often seek intervention too late, and there are no satisfactory treatments for dementia. There is a crucial need for early detection.
Neurologist at a Public Hospital, China